Figure 2: FGF19 (30 μg) corrects hyperglycemia in T1D rats by suppression of the hypothalamic–pituitary–adrenal axis.
From: FGF1 and FGF19 reverse diabetes by suppression of the hypothalamic–pituitary–adrenal axis
(a–c) Plasma glucose, NEFA and glycerol concentrations. (d–e) Fasting plasma insulin and glucagon concentrations. (f–j) Plasma corticosterone, ACTH, epinephrine, norepinephrine and growth hormone concentrations. Data are representative of mean±s.e.m. of n=6 per group, with comparisons by analysis of variance with Bonferroni’s multiple comparisons test.
